Taking a closer look at eye cancer: Research offers new insight into high rate of metastasis

byEdith Cowan UniversityCredit: Marc Schulte from PexelsNew research from Edith Cowan University (ECU) is one step closer to understanding why uveal melanoma, the deadliest form of eye cancer, h

Updated on: August 01,2024

Taking a closer look at eye cancer: Research offers new insight into high rate of metastasis

byEdith Cowan UniversityCredit: Marc Schulte from PexelsNew research from Edith Cowan University (ECU) is one step closer to understanding why uveal melanoma, the deadliest form of eye cancer, h

Updated on:August 01,2024

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Updated on: May 11,2024

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Updated on:May 11,2024

Researchers find new way to target childhood cancer

by Children's Cancer Institute AustraliaCredit: CC0 Public DomainAn Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the child

Updated on: June 01,2024

Researchers find new way to target childhood cancer

by Children's Cancer Institute AustraliaCredit: CC0 Public DomainAn Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the child

Updated on:June 01,2024

Research shows that DOPA protects against melanoma

byPerelman School of Medicine at the University of PennsylvaniaHistologic characterization of representative orthotopic skin and resulting tumors, including MC and proliferation markers MITF (re

Updated on: January 22,2024

Research shows that DOPA protects against melanoma

byPerelman School of Medicine at the University of PennsylvaniaHistologic characterization of representative orthotopic skin and resulting tumors, including MC and proliferation markers MITF (re

Updated on:January 22,2024

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch

Updated on: December 01,2024

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch

Updated on:December 01,2024

Study finds triple-negative breast cancer tumors with increased immune cells have lower risk of recurrence after surgery

by Mayo ClinicCredit: Unsplash/CC0 Public DomainA new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cel

Updated on: April 06,2024

Study finds triple-negative breast cancer tumors with increased immune cells have lower risk of recurrence after surgery

by Mayo ClinicCredit: Unsplash/CC0 Public DomainA new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cel

Updated on:April 06,2024

Method that rapidly predicts breast cancer survival rates clinically validated

by Ian Mundell,Imperial College LondonFlow diagram of the Digistain protocol. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s10549-023-07229-yDigistain, a company w

Updated on: March 05,2024

Method that rapidly predicts breast cancer survival rates clinically validated

by Ian Mundell,Imperial College LondonFlow diagram of the Digistain protocol. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s10549-023-07229-yDigistain, a company w

Updated on:March 05,2024

AI with infrared imaging enables precise colon cancer diagnostics

byRuhr-Universitaet-BochumGraphical abstract. Credit:European Journal of Cancer(2023). DOI: 10.1016/j.ejca.2022.12.026The immense progress in the field of therapy options over the pa

Updated on: December 25,2023

AI with infrared imaging enables precise colon cancer diagnostics

byRuhr-Universitaet-BochumGraphical abstract. Credit:European Journal of Cancer(2023). DOI: 10.1016/j.ejca.2022.12.026The immense progress in the field of therapy options over the pa

Updated on:December 25,2023

Researchers uncover on/off switch for breast cancer metastasis

by Rebecca McClellan,Stanford UniversitySongnan Wang (left) and Lingyin Li (right) found that a protein called ENPP1 acts as an on/off switch for breast cancer metastases. High protein levels le

Updated on: December 28,2023

Researchers uncover on/off switch for breast cancer metastasis

by Rebecca McClellan,Stanford UniversitySongnan Wang (left) and Lingyin Li (right) found that a protein called ENPP1 acts as an on/off switch for breast cancer metastases. High protein levels le

Updated on:December 28,2023

Stomach cancers make electrical connections with the nervous system to fuel spread, study finds

Updated on: April 29,2025

Stomach cancers make electrical connections with the nervous system to fuel spread, study finds

Updated on:April 29,2025

Study proposes streamlined approach to developing cancer drugs

by Tom Dinki,University at BuffaloBlessing Ogboo works in the Natural Sciences Complex chemistry lab of David Heppner. Credit: Douglas Levere / Univeristy at BuffaloDrug discovery can be a frust

Updated on: June 25,2024

Study proposes streamlined approach to developing cancer drugs

by Tom Dinki,University at BuffaloBlessing Ogboo works in the Natural Sciences Complex chemistry lab of David Heppner. Credit: Douglas Levere / Univeristy at BuffaloDrug discovery can be a frust

Updated on:June 25,2024

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Updated on: January 04,2024

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Updated on:January 04,2024